Midas Minerals and Kuda Gold recorded the best lithium exploration results this morning

Nick Sundich Nick Sundich, December 12, 2023

There were a flurry of lithium exploration results this morning, but Midas Minerals (ASX:MM1) and Kuda Gold (ASX:KGD) stood out. The former of these lithium stocks recorded amongst the highest-grade results recorded in several weeks.

 

Midas Minerals records up to 7.25% lithium

Midas has a project in Canada’s Northwest Territories. Although it is at early stage exploration – at the sampling stage rather than drilling – it now has 30 samples and the results are not to be snuffed at. The best result was 7.25% lithium, with others including 5.55%, 5.12% and 3.97%.

The company claims that it has covered less than 1% of the project area, so there is scope for further discoveries. Nonetheless, it as immediately applied for a drilling permit in those areas.

 

Kuda Gold is prospecting for lithium

Notwithstanding this company’s name, one of is projects is the Kirup lithium project that lies just 20km from the Greenbushes lithium mine in WA. Unlike Midas, Kuda is at the drilling stage, although it has not reported formal grades. Rather, it reported visual pegmatites in multiple intervals varying from 3m to interpreted 55m thick.

Pegmatite is an igneous rock that is created underground when interlocking crystals. Even though mere pegmatites do not imply the presence of lithium, as the company stressed, pegmatites can be a common source for lithium. And this is why share in this company rose this morning.

 

What are the Best ASX Stocks to invest in right now?

Check our ASX buy/sell tips

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Kamala Harris stocks

Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?

With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…

South32

South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?

South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…

drug reimbursement

Here’s why drug reimbursement is so important for ASX healthcare stocks

Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…